Podophyllotoxin-polyacrylic acid conjugate micelles: improved anticancer efficacy against multidrug-resistant breast cancer

Journal of the Egyptian National Cancer Institute - Tập 32 Số 1 - 2020
Popat Kumbhar1, Asmita M Sakate1, Onkar B. Patil1, Arehalli S. Manjappa1, John Disouza1
1Department of Pharmaceutics, Tatyasaheb Kore College of Pharmacy, Warananagar, Panhala, Kolhapur, Maharashtra, 416113, India

Tóm tắt

Abstract Background Podophyllotoxin (PPT) is a naturally occurring compound obtained from the roots of Podophyllum species, indicated for a variety of malignant tumors such as breast, lung, and liver tumors. This toxic polyphenol (PPT) exhibited significant activity against P-glycoprotein (P-gp) mediated multidrug-resistant (MDR) cancer cells. However, extremely poor water solubility, a narrow therapeutic window, and high toxicity have greatly restricted the clinical uses of PPT. Therefore, the present research was aimed to synthesize the water-soluble ester prodrug of PPT with polyacrylic acid (PAA), a water-soluble polymer by Steglich esterification reaction, and to screen it for assay, solubility, in vitro hemolysis, in vitro release, and in vitro anticancer activity. Results The Fourier transform infrared (FTIR) and nuclear magnetic resonance (NMR) spectroscopy results revealed the successful synthesis of podophyllotoxin-polyacrylic acid conjugate (PPC). The assay and saturation solubility of the prodrug is found to be 64.01 ± 4.5% and 1.39 ± 0.05 mg/mL (PPT equivalent) respectively. The PPC showed CMC (critical micelle concentration) of 0.430 mg/mL in distilled water at room temperature. The PPC micelles showed a mean particle size of 215 ± 11 nm with polydispersity index (PDI) of 0.193 ± 0.006. Further, the transmission electron microscope (TEM) results confirmed the self-assembling character of PPC into micelles. The PPC caused significantly less hemolysis (18.6 ± 2.9%) than plain PPT solution. Also, it demonstrated significantly (p < 0.01) higher in vitro cytotoxicity against both sensitive as well as resistance human breast cancer cells (MCF-7 and MDA MB-231) after 48 h of treatment. Conclusion The obtained study results clearly revealed the notable in vitro anticancer activity of PPT following its esterification with PAA. However, further in vivo studies are needed to ascertain its efficacy against a variety of cancers.

Từ khóa


Tài liệu tham khảo

Liang L, Lin SW, Dai W, Lu JK, Yang TY, Xiang Y, et al. Novel cathepsin B-sensitive paclitaxel conjugate: higher water solubility, better efficacy and lower toxicity. J Control Release. 2012;160:618–29.

Xue YH, Zhang R, Sun XY, Wang SL. The construction and characterization of layered double hydroxides as delivery vehicles for podophyllotoxins. J Mater Sci Mater Med. 2008;19:1197–202.

Fouad Y, Aanei C. Revisiting the hallmarks of cancer. Am J Cancer Res. 2017;7(5):1016–36.

Yu X, Che Z, Xu H. Recent advances in the chemistry and biology of podophyllotoxins. Chemistry. 2017;23(19):4467–526.

Roy AM, Ernsting J, Undzys E, Li SD. A highly tumor-targeted nanoparticle of podophyllotoxin penetrated tumor core and regressed multidrug resistant tumors. Biomaterials. 2015;52:335–46.

Huicong Z, Shixian L, Dawei Z, Mingxiao D, Xuefei Z, Zhaohui T, Xuesi C. A polypeptide based podophyllotoxin conjugate for the treatment of multi drug resistant breast cancer with enhanced efficiency and minimal toxicity. Acta Biomater. 2018;73:388–99.

Subrahmanyam D, Renuka B, Rao CV, Sagar PS, Deevi DS, Babu JM, et al. Novel D-ring analogues of podophyllotoxin as potent anti-cancer agents. Bioorg Med Chem Lett. 1998;8(11):1391–6.

Giri A, Lakshmi NM. Production of podophyllotoxin from Podophyllum hexandrum: a potential natural product for clinically useful anticancer drugs. Cytotechnology. 2000;34:17–26.

Liu YQ, Yang L, Tian X. Podophyllotoxin: Current perspective. Curr Bioact Compd. 2007;3:37–66.

Koziara JM, Whisman TR, Tseng MT, Mumper RJ. In-vivo efficacy of novel paclitaxel nanoparticles in paclitaxel-resistant human colorectal tumors. J Control Release. 2006;112(3):312–9.

Manjappa AS, Kumbhar PS, Khopade PS, Patil AB, Disouza JI. Mixed micelles as nano polymer therapeutics of docetaxel: increased in vitro cytotoxicity and decreased in vivo toxicity. Curr Drug Deliv. 2018;15(4):564–75.

Goel PN, Gude RP. Unraveling the antimetastatic potential of pentoxifylline, a methylxanthine derivative in human MDA-MB- 231 breast cancer cells. Mol Cell Biochem. 2011;358(1-2):141–51.

Chen C, Yu Y, Wang X, Shi P, Wang Y, Wang P. Manipulation of pH-sensitive interactions between podophyllotoxin-chitosan for enhanced controlled drug release. Int J Biol Macromol. 2017;95:451–61.

Wang Y, Huang L, Shen Y, Tang L, Sun R, Shi D, et al. Electrostatic interactions between polyglutamic acid and polylysine yields stable polyion complex micelles for deoxypodophyllotoxin delivery. Int J Nanomedicine. 2017;12:7963–77.

Greenwald RB, Conover CD, Pendri A, Choe YH, Martinez A, Wu D, et al. Drug delivery of anticancer agents: water soluble 4-poly (ethylene glycol) derivatives of the lignan, podophyllotoxin. J Control Release. 1999;61(3):281–94.

Zhang W, Lin W, Pei Q, Hu X, Xie Z, Jing X. Redox-hypersensitive organic nanoparticles for selective treatment of cancer cells. Chem. Mater. 2016;28(12):4440–6.

Murat T, Rabia CK, Sevil DI, Melahat B, Zeynep A, Serhat E, et al. Conjugation, characterization and toxicity of lipophosphoglycan-polyacrylic acid conjugate for vaccination against leishmaniasis. J Biomed Sci. 2013;20(1):20–35.

Manjappa AS, Kumbhar PS, Kasabe R, Diwate S, Disouza JI. Ameliorated in vitro anticancer efficacy of methotrexate D-α-tocopheryl polyethylene glycol 1000 succinate ester against breast cancer cells. Future J Pharmaceutical Sci. 2019;5(10):1–10.

Kumbhar PS, Birange S, Atvale M, Manjappa AS, Disouza JI. D-gluconic acid based methotrexate prodrug loaded mixed micelles composed of MDR reversing copolymer: in vitro and in vivo results. Colloid Polym Sci. 2018;296(12):1971–81.

Kumbhar PS, Patil NJ, Sambamoorthy U, Disouza JI, Manjappa AS. Simvastatin loaded nano mixed micelles: an approach to treat hormone dependent carcinomas. Int J Pharmaceutical Sci Res. 2019;10(2):546–54.

Utsugi T, Shibata J, Sugimoto Y, Aoyagi K, Wierzba K, Kobunai T, et al. Antitumor activity of a novel podophyllotoxin derivative (top-53) against lung cancer and lung metastatic cancer. Cancer Res. 1996;56(12):2809–14.

Bromberg L. Polyether-modified poly (acrylic acid): synthesis and applications. Ind Eng Chem Res. 1998;37(11):4267–74.

Levy RK, Hall IH, Leex K. Antitumor agents LXII: synthesis and biological evaluation of podophyllotoxin esters and related derivatives. Am Pharmaceutical Assoc. 1983;72:1158–61.

Li Y, Chen M, Yao B, Lu X, Zhang X, He P, et al. Transferrin receptor-targeted redox/pH-sensitive podophyllotoxin prodrug micelles for multidrug-resistant breast cancer therapy. J Mater Chem B. 2019;7(38):5814–24.

Manjappa AS, Kumbhar PS, Patil AB, Disouza JI. Polymeric mixed micelles: improving the anticancer efficacy of single-copolymer micelles. Crit Rev Ther Drug Carrier Syst. 2019;36(1):1–58.

Thông tin
Thông tin xuất bản

Journal of the Egyptian National Cancer Institute

Tập 32 Số 1

Thông tin tác giả